GLYRIVA 50mcg BEXICAP contains Glycopyrronium Bromide 50 mcg. It is a long-acting muscarinic antagonist (LAMA) bronchodilator used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) by relaxing airway muscles and improving airflow.
Uses:
Maintenance treatment of chronic obstructive pulmonary disease (COPD).
Relief of airflow obstruction.
Helps reduce breathlessness and wheezing.
Improves lung function and quality of life in patients with COPD.
Dose:
Adults: Usually 1 inhalation once daily, or as directed by a physician.
Use the BEXICAP inhalation device exactly as instructed by a healthcare professional.
Do not swallow the capsule; it is for inhalation only.
Dose and duration depend on the patient's condition and response to treatment.